What is the Ars Pharmaceuticals Inc stock price forecast?

Ars Pharmaceuticals Inc is currently trading at $9.70. View real-time AI analysis on Alpha Lenz.

What is Ars Pharmaceuticals Inc insider trading activity?

View the latest insider trading data for Ars Pharmaceuticals Inc on Alpha Lenz.

What is Ars Pharmaceuticals Inc's P/E ratio?

View Ars Pharmaceuticals Inc's valuation metrics on Alpha Lenz.

Ars Pharmaceuticals Inc

NASDAQ · SPRY

$9.70-0.11(-1.12%)Pre-market

Ask about Ars Pharmaceuticals Inc's future dividend policy...

Alpha Chat Insight

“Ars Pharmaceuticals Inc's ROE is -92.3%. Explore profitability and growth together.”

Ask for details →

Company Overview

SectorUnknown

IndustryUnknown

Company Statistics

FY 2025

Profile

N/AMarket Cap

$84.28MRevenue

0.00Shares Out

N/AEmployees

Margins

75.77%Gross

-200.26%EBITDA

-212.92%Operating

-203.35%Pre-Tax

-203.25%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

300.09%Rev 3Yr

36.42%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-50.47%ROA

-92.33%ROE

-49.73%ROIC

Financial Health

$41.32MCash & Cash Equivalents

$172.08MNet Debt

186.76%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Ars Pharmaceuticals Inc's ROE is -92.3%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

Ars Pharmaceuticals Inc (ticker: SPRY) is a company listed on NASDAQ in the Unknown sector (Unknown).

The current price is $9.7 with a P/E ratio of -x and P/B of -x.

ROE is -92.33% and operating margin is -212.92%. Annual revenue is $84M.